Bicalutamide + Goserelin

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Bicalutamide bicalutamide
Goserelin goserelin

Brands with this exact combination

Brand	Composition & strength	Manufacturer
goserelin + bicalutamideAU	3.6 mg / 50 mg / 10.8 mg	AstraZeneca Pty Ltd
ZolaCos CP Combination Goserelin 3.6mg (as Acetate) Implant Syringe and Bicalutamide 50mg tablet blister packAU	tablet Bicalutamide 50 mg + Goserelin 10.8 mg tablet Bicalutamide 50 mg + Goserelin 3.6 mg	AstraZeneca Pty Ltd
ZolaCos CP 3.6/50AU	tablet Bicalutamide 50 mg + Goserelin 3.6 mg	AstraZeneca Pty Ltd
ZolaCos CP 10.8/50(28)AU	tablet Bicalutamide 50 mg + Goserelin 10.8 mg	AstraZeneca Pty Ltd
ZolaCos CP 10.8/50(84)AU	tablet Bicalutamide 50 mg + Goserelin 10.8 mg	AstraZeneca Pty Ltd
ZolaCos CPAU	unknown Bicalutamide + Goserelin	—

Same combination in other markets

No product with this combination is recorded in the other covered markets yet.

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.